|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 164.42 USD | -2.46% |
|
-12.37% | -6.57% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.22 | 8.86 | 7.78 | 4.58 | 5.29 | |||||
Return on Total Capital | 15.16 | 11.53 | 9.72 | 5.56 | 6.36 | |||||
Return On Equity % | 33.8 | 15.96 | 24.33 | 8.24 | 10.36 | |||||
Return on Common Equity | 33.28 | 14.41 | 25.08 | 8.24 | 10.36 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 86.57 | 80.79 | 77.61 | 74.24 | 76.12 | |||||
SG&A Margin | 18.68 | 24.41 | 23.72 | 25.44 | 24.67 | |||||
EBITDA Margin % | 38.03 | 35.73 | 34.73 | 24.17 | 30.96 | |||||
EBITA Margin % | 36.52 | 33.58 | 32.05 | 21.58 | 28 | |||||
EBIT Margin % | 34.63 | 31.29 | 29.63 | 19.14 | 24 | |||||
Income From Continuing Operations Margin % | 30.2 | 15.73 | 29.11 | 11.81 | 16.87 | |||||
Net Income Margin % | 29.76 | 14.17 | 29.95 | 11.8 | 16.87 | |||||
Net Avail. For Common Margin % | 29.76 | 14.17 | 29.95 | 11.8 | 16.87 | |||||
Normalized Net Income Margin | 20.39 | 16.66 | 18.17 | 11.81 | 13.45 | |||||
Levered Free Cash Flow Margin | 21.42 | 20.09 | 13.67 | 9.87 | 33.76 | |||||
Unlevered Free Cash Flow Margin | 22.41 | 21.54 | 15.18 | 11.44 | 35.38 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.52 | 0.45 | 0.42 | 0.38 | 0.35 | |||||
Fixed Assets Turnover | 3.58 | 2.88 | 2.71 | 2.65 | 2.66 | |||||
Receivables Turnover (Average Receivables) | 5.28 | 4.9 | 4.73 | 4.64 | 4.88 | |||||
Inventory Turnover (Average Inventory) | 1.93 | 1.74 | 1.69 | 1.31 | 0.93 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.84 | 1.83 | 2.99 | 2 | 1.35 | |||||
Quick Ratio | 1.32 | 1.34 | 2.39 | 1.04 | 0.77 | |||||
Operating Cash Flow to Current Liabilities | 1.13 | 0.85 | 0.42 | 0.45 | 0.52 | |||||
Days Sales Outstanding (Average Receivables) | 69.3 | 74.51 | 77.2 | 78.61 | 75.06 | |||||
Days Outstanding Inventory (Average Inventory) | 189.85 | 209.35 | 215.95 | 278.91 | 395.08 | |||||
Average Days Payable Outstanding | 87.16 | 79.64 | 86.84 | 43.94 | 67.5 | |||||
Cash Conversion Cycle (Average Days) | 171.99 | 204.22 | 206.31 | 313.58 | 402.64 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 74.03 | 70.19 | 50.13 | 50.19 | 40.18 | |||||
Total Debt / Total Capital | 42.54 | 41.24 | 33.39 | 33.42 | 28.66 | |||||
LT Debt/Equity | 73.26 | 60.26 | 49.4 | 48.57 | 29.2 | |||||
Long-Term Debt / Total Capital | 42.09 | 35.41 | 32.91 | 32.34 | 20.83 | |||||
Total Liabilities / Total Assets | 56.59 | 54.1 | 45.47 | 44.87 | 40.4 | |||||
EBIT / Interest Expense | 21.85 | 13.55 | 12.22 | 7.62 | 9.28 | |||||
EBITDA / Interest Expense | 24.42 | 15.86 | 14.71 | 10.2 | 12.47 | |||||
(EBITDA - Capex) / Interest Expense | 22.43 | 14.84 | 13.74 | 9.07 | 11.85 | |||||
Total Debt / EBITDA | 1.52 | 1.91 | 1.85 | 2.95 | 2.15 | |||||
Net Debt / EBITDA | 0.87 | 0.75 | 0.31 | 2.53 | 1.39 | |||||
Total Debt / (EBITDA - Capex) | 1.66 | 2.04 | 1.98 | 3.32 | 2.26 | |||||
Net Debt / (EBITDA - Capex) | 0.95 | 0.8 | 0.33 | 2.85 | 1.46 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.49 | -18.32 | -7.36 | -3.32 | -1.62 | |||||
Gross Profit, 1 Yr. Growth % | -6.3 | -23.78 | -11.01 | -7.51 | 0.87 | |||||
EBITDA, 1 Yr. Growth % | -33.98 | -23.26 | -9.83 | -32.79 | 26.03 | |||||
EBITA, 1 Yr. Growth % | -34.99 | -24.9 | -11.45 | -34.98 | 27.61 | |||||
EBIT, 1 Yr. Growth % | -36.05 | -26.2 | -12.12 | -37.64 | 23.39 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -31.04 | -57.45 | 71.43 | -60.78 | 40.53 | |||||
Net Income, 1 Yr. Growth % | -32.06 | -61.1 | 95.8 | -61.89 | 40.57 | |||||
Normalized Net Income, 1 Yr. Growth % | -38.02 | -33.27 | 0.93 | -37.14 | 12.01 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -21.07 | -58.06 | 100.67 | -61.81 | 40.28 | |||||
Accounts Receivable, 1 Yr. Growth % | -5.8 | -15.71 | 8.91 | -1.7 | -11.01 | |||||
Inventory, 1 Yr. Growth % | 32.88 | 26.47 | -0.53 | 87.99 | -2.65 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.64 | -1.38 | -2.36 | 0.73 | -5.15 | |||||
Total Assets, 1 Yr. Growth % | -9.6 | -3.01 | 2.83 | 9.33 | 4.49 | |||||
Tangible Book Value, 1 Yr. Growth % | -54.32 | 57.17 | 99.01 | -96.25 | 151.34 | |||||
Common Equity, 1 Yr. Growth % | -19.81 | 1.83 | 22.96 | 10.46 | 12.95 | |||||
Cash From Operations, 1 Yr. Growth % | -40.25 | -13.95 | -61.97 | 11.77 | 85.85 | |||||
Capital Expenditures, 1 Yr. Growth % | -17.43 | -39.24 | -6.9 | 15.27 | -44.51 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -37.93 | -23.4 | -36.93 | -30.3 | 236.43 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -36.65 | -21.52 | -34.59 | -27.27 | 204.2 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.03 | -12.6 | -13.01 | -5.36 | -2.48 | |||||
Gross Profit, 2 Yr. CAGR % | 0.01 | -15.49 | -17.64 | -9.28 | -3.41 | |||||
EBITDA, 2 Yr. CAGR % | -14.63 | -28.8 | -16.84 | -22.16 | -7.97 | |||||
EBITA, 2 Yr. CAGR % | -14.68 | -30.11 | -18.48 | -24.13 | -8.91 | |||||
EBIT, 2 Yr. CAGR % | -14.47 | -31.28 | -19.5 | -25.98 | -12.28 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -4.73 | -45.84 | -14.6 | -18 | -25.76 | |||||
Net Income, 2 Yr. CAGR % | -4.98 | -48.59 | -12.73 | -13.62 | -26.81 | |||||
Normalized Net Income, 2 Yr. CAGR % | -15.81 | -35.69 | -17.89 | -20.35 | -16.09 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 7.2 | -42.47 | -8.26 | -12.46 | -26.81 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.23 | -10.89 | -4.19 | 3.46 | -6.47 | |||||
Inventory, 2 Yr. CAGR % | 7.2 | 29.64 | 12.16 | 36.75 | 35.28 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.33 | 1.59 | -1.87 | -0.82 | -2.25 | |||||
Total Assets, 2 Yr. CAGR % | -1.33 | -6.37 | -0.13 | 6.03 | 6.88 | |||||
Tangible Book Value, 2 Yr. CAGR % | -33.67 | -15.26 | 76.86 | -72.7 | -69.32 | |||||
Common Equity, 2 Yr. CAGR % | -9.41 | -9.63 | 11.9 | 16.54 | 11.7 | |||||
Cash From Operations, 2 Yr. CAGR % | -17.32 | -28.29 | -42.79 | -34.8 | 44.13 | |||||
Capital Expenditures, 2 Yr. CAGR % | -25.75 | -29.17 | -24.79 | 3.6 | -20.02 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -12.92 | -31.03 | -30.49 | -33.69 | 53.13 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.36 | -29.48 | -28.37 | -31.02 | 48.75 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.08 | -6.54 | -10.89 | -9.89 | -4.13 | |||||
Gross Profit, 3 Yr. CAGR % | 3.03 | -8.65 | -14.02 | -14.39 | -6.01 | |||||
EBITDA, 3 Yr. CAGR % | -8.2 | -17.61 | -23.01 | -22.51 | -8.6 | |||||
EBITA, 3 Yr. CAGR % | -8.17 | -18.23 | -24.41 | -24.37 | -9.77 | |||||
EBIT, 3 Yr. CAGR % | -7.52 | -18.57 | -25.45 | -26.03 | -12.24 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 15 | -27.18 | -20.47 | -34.11 | -1.88 | |||||
Net Income, 3 Yr. CAGR % | 16.36 | -29.45 | -19.72 | -33.79 | 1.6 | |||||
Normalized Net Income, 3 Yr. CAGR % | -7.25 | -22.09 | -25.23 | -24.89 | -10.76 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 27.66 | -21.6 | -12.75 | -31.5 | 2.44 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.11 | -7.58 | -4.73 | -3.37 | -1.6 | |||||
Inventory, 3 Yr. CAGR % | 5.78 | 13.27 | 18.68 | 33.24 | 22.11 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.51 | 1.73 | 0.26 | -1.01 | -2.29 | |||||
Total Assets, 3 Yr. CAGR % | 1.34 | -1.9 | -3.39 | 2.93 | 5.51 | |||||
Tangible Book Value, 3 Yr. CAGR % | -23.25 | -11.57 | 12.64 | -51.07 | -42.78 | |||||
Common Equity, 3 Yr. CAGR % | -5.33 | -5.81 | 0.14 | 11.42 | 15.33 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.41 | -16.21 | -41.96 | -28.48 | -7.56 | |||||
Capital Expenditures, 3 Yr. CAGR % | -21.18 | -30.55 | -22.41 | -13.28 | -15.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 12.12 | -16.56 | -33.07 | -30.38 | 13.94 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.05 | -15.53 | -31.26 | -27.97 | 13.12 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.55 | -0.83 | -3.68 | -6.07 | -7.62 | |||||
Gross Profit, 5 Yr. CAGR % | 4.09 | -2.4 | -5.8 | -8.9 | -9.93 | |||||
EBITDA, 5 Yr. CAGR % | -1.86 | -9.17 | -11.77 | -19.46 | -17.29 | |||||
EBITA, 5 Yr. CAGR % | -1.87 | -9.52 | -12.46 | -20.64 | -18.53 | |||||
EBIT, 5 Yr. CAGR % | -1.48 | -9.66 | -12.53 | -21.62 | -20.42 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.48 | -14.11 | 2.09 | -23.64 | -22.63 | |||||
Net Income, 5 Yr. CAGR % | 2.44 | -15.92 | 3.71 | -23.5 | -22.63 | |||||
Normalized Net Income, 5 Yr. CAGR % | -1.82 | -11.85 | -11.66 | -21.38 | -21.7 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.08 | -9.29 | 11.85 | -18.06 | -18.67 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.59 | 2.4 | -1.63 | -3.31 | -5.43 | |||||
Inventory, 5 Yr. CAGR % | 3.65 | 6.18 | 8.29 | 22.14 | 25.06 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.94 | 8.67 | 3.07 | 0.7 | -0.75 | |||||
Total Assets, 5 Yr. CAGR % | 4.77 | 0.86 | 0.75 | 1.2 | 0.59 | |||||
Tangible Book Value, 5 Yr. CAGR % | -6.71 | -8.97 | 7.18 | -44.74 | -33.05 | |||||
Common Equity, 5 Yr. CAGR % | 2.68 | -2.14 | 1.22 | 2.56 | 4.61 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.54 | -4.52 | -21.18 | -24.21 | -16.49 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.96 | -15.97 | -22.64 | -18.51 | -21.47 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -0.74 | -10.22 | -7.41 | -23.87 | -6.77 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -0.23 | -9.72 | -6.83 | -22.1 | -6.36 |
- Stock Market
- Equities
- BIIB Stock
- Financials Biogen Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















